Guangzhou Cellprotek Pharmaceutical
↗Guangzhou, China
Guangzhou Cellprotek is a clinical-stage biopharmaceutical company dedicated to solving unmet clinical needs in chronic neurodegenerative and acute cerebrovascular diseases. Founded in 2011 and headquartered in Guangzhou Science City, the company focuses on the research and development of innovative small molecule drugs, particularly for central nervous system (CNS) disorders, cardiovascular diseases, and severe inflammatory conditions.
The company's core technology platform is centered on synthetic steroids with neuroprotective and anti-inflammatory properties. Its lead candidate, YC-6 (An-nao-san-chun), has shown significant potential in treating acute ischemic stroke, malignant cerebral infarction, and intracerebral hemorrhage. CellProtek has been recognized as a 'High-Tech Enterprise' and one of the 'Top 100 Most Innovative Pharmaceutical Companies in Asia-Pacific' (SME category).
CLASSIFICATION
SIZE & FINANCIALS
Employees:51-200
Revenue:$1M-$10M (pre-commercial)
Founded:2011
Ownership:private
Status:operating
FUNDING
Stage:Series B / Secondary Transaction
Investors:Angel investors, Private equity (Secondary market)
PIPELINE
Stage:Phase 3 (Planning)
Lead Drug Stage:Phase 2/3
Modalities:Small molecule, Synthetic steroid
Active Trials:4
Trial Phases:Phase 1: 2 | Phase 2: 2
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Beijing Tiantan Hospital (Clinical trial collaboration), Peking Union Medical College Hospital
COMPETITION
Position:Emerging
Competitors:Simcere Pharmaceutical, Luye Pharma, Zai Lab, Biogen
LEADERSHIP
Key Executives:
Wang Wei - Chairman
Li Qun - General Manager
Yan Guangmei - Chief Scientist
Scientific Founders:Yan Guangmei
Board Members:Wang Wei, Li Qun
LINKS
Website:cellprotek.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Guangzhou Cellprotek Pharmaceutical. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.